Allergy Asthma Immunol Res.  2018 Jan;10(1):12-17. 10.4168/aair.2018.10.1.12.

Viral Infections and Associated Factors That Promote Acute Exacerbations of Asthma

Affiliations
  • 1Asthma and Allergy Center, Inje University Sanggye Paik Hospital, Seoul, Korea.
  • 2School of Biological Sciences, University of Ulsan, Ulsan, Korea.
  • 3Departments of Pediatrics and Medicine, University of Wisconsin-Madison, Madison, WI, USA. gern@medicine.wisc.edu

Abstract

Despite asthma being the most common chronic childhood ailment, there is still much to learn about the disease. Early childhood infections with well-known or emerging viruses can lay the pathophysiologic framework for asthma development and exacerbation later in life, which may be due partly to alteration of the airway microbiome. Once asthma is established, acute exacerbations are usually associated with infections with respiratory viruses, such as rhinoviruses (RVs). Once again, there are bidirectional interactions between viruses and airway bacteria that appear to influence the severity of illness and the likelihood of exacerbation. Studies employing recent advances in viral and bacterial identification analytic techniques will clarify these new concepts and may provide the basis for new treatments or prevention or respiratory infection-associated exacerbation. This paper is a review of the associations among respiratory viruses, bacteria, inflammatory mechanisms, and asthma exacerbation.

Keyword

Asthma exacerbation; co-infection; emerging viruses; eosinophils; inflammatory mediators

MeSH Terms

Asthma*
Bacteria
Coinfection
Eosinophils
Microbiota
Rhinovirus

Figure

  • Figure Factors that can influence the severity of RV infections and the risk of RV-induced exacerbations of asthma. In children and adults with asthma, the severity of RV infection is positively related to the probability of exacerbation. Factors that increase the likelihood of more severe RV illnesses and exacerbations of asthma include the species of RV, the presence of bacterial pathogens in the airway, allergic inflammation, and polymorphisms in CDHR3 and the 17q21 region of the genome. RV, rhinovirus; CDHR3, cadherin-related protein-3; IgE, immunoglobulin E; Eos, eosinophils.


Cited by  3 articles

Montelukast Reduces Serum Levels of Eosinophil-Derived Neurotoxin in Preschool Asthma
Chang-Keun Kim, Zak Callaway, Jin-Sung Park, Hisashi Nishimori, Tikatoshi Ogino, Mizuho Nagao, Takao Fujisawa
Allergy Asthma Immunol Res. 2018;10(6):686-697.    doi: 10.4168/aair.2018.10.6.686.

Association Between Epithelial Cytokines and Clinical Phenotypes of Elderly Asthma
Bastsetseg Ulambayar, So-Hee Lee, Eun-Mi Yang, Young-Min Ye, Hae-Sim Park
Allergy Asthma Immunol Res. 2019;11(1):79-89.    doi: 10.4168/aair.2019.11.1.79.

Associated Factors for Asthma Severity in Korean Children: A Korean Childhood Asthma Study
Eun Lee, Dae Jin Song, Woo Kyung Kim, Dong In Suh, Hey-Sung Baek, Meeyong Shin, Young Yoo, Jin Tack Kim, Ji-Won Kwon, Gwang Cheon Jang, Dae Hyun Lim, Hyeon-Jong Yang, Hwan Soo Kim, Ju-Hee Seo, Sung-Il Woo, Hyung Young Kim, Youn Ho Shin, Ju Suk Lee, Jisun Yoon, Sungsu Jung, Minkyu Han, Eunjin Eom, Jinho Yu
Allergy Asthma Immunol Res. 2020;12(1):86-98.    doi: 10.4168/aair.2020.12.1.86.


Reference

1. Cheung D, Dick EC, Timmers MC, de Klerk EP, Spaan WJ, Sterk PJ. Rhinovirus inhalation causes long-lasting excessive airway narrowing in response to methacholine in asthmatic subjects in vivo. Am J Respir Crit Care Med. 1995; 152:1490–1496. PMID: 7582282.
2. Fraenkel DJ, Bardin PG, Sanderson G, Lampe F, Johnston SL, Holgate ST. Lower airways inflammation during rhinovirus colds in normal and in asthmatic subjects. Am J Respir Crit Care Med. 1995; 151:879–886. PMID: 7881686.
Article
3. Kloepfer KM, Lee WM, Pappas TE, Kang TJ, Vrtis RF, Evans MD, et al. Detection of pathogenic bacteria during rhinovirus infection is associated with increased respiratory symptoms and asthma exacerbations. J Allergy Clin Immunol. 2014; 133:1301–1307. 1307.e1–1307.e3. PMID: 24698319.
Article
4. Murray CS, Poletti G, Kebadze T, Morris J, Woodcock A, Johnston SL, et al. Study of modifiable risk factors for asthma exacerbations: virus infection and allergen exposure increase the risk of asthma hospital admissions in children. Thorax. 2006; 61:376–382. PMID: 16384881.
Article
5. Olenec JP, Kim WK, Lee WM, Vang F, Pappas TE, Salazar LE, et al. Weekly monitoring of children with asthma for infections and illness during common cold seasons. J Allergy Clin Immunol. 2010; 125:1001–1006.e1. PMID: 20392488.
Article
6. Global Asthma Network (NZ). The global asthma report 2014 [Internet]. Auckland: Global Asthma Network;2014. cited 2016 Jun 27. Available from: http://www.globalasthmareport.org/burden/burden.php.
7. Wark PA, Gibson PG. Asthma exacerbations · 3: pathogenesis. Thorax. 2006; 61:909–915. PMID: 17008482.
8. National Asthma Education and Prevention Program (US). Expert panel report 3 (EPR-3): guidelines for the diagnosis and management of asthma: full report. Bethesda (MD): National Heart, Lung, and Blood Institute;2007.
9. Pizzichini MM, Pizzichini E, Clelland L, Efthimiadis A, Pavord I, Dolovich J, et al. Prednisone-dependent asthma: inflammatory indices in induced sputum. Eur Respir J. 1999; 13:15–21. PMID: 10836317.
Article
10. Green RH, Brightling CE, McKenna S, Hargadon B, Parker D, Bradding P, et al. Asthma exacerbations and sputum eosinophil counts: a randomised controlled trial. Lancet. 2002; 360:1715–1721. PMID: 12480423.
Article
11. Johnston SL, Pattemore PK, Sanderson G, Smith S, Lampe F, Josephs L, et al. Community study of role of viral infections in exacerbations of asthma in 9–11 year old children. BMJ. 1995; 310:1225–1229. PMID: 7767192.
Article
12. Grissell TV, Powell H, Shafren DR, Boyle MJ, Hensley MJ, Jones PD, et al. Interleukin-10 gene expression in acute virus-induced asthma. Am J Respir Crit Care Med. 2005; 172:433–439. PMID: 15894599.
Article
13. Kim CK, Choi J, Callaway Z, Kim HB, Chung JY, Koh YY, et al. Clinical and epidemiological comparison of human metapneumovirus and respiratory syncytial virus in Seoul, Korea, 2003–2008. J Korean Med Sci. 2010; 25:342–347. PMID: 20191030.
Article
14. Matsuse H, Kondo Y, Saeki S, Nakata H, Fukushima C, Mizuta Y, et al. Naturally occurring parainfluenza virus 3 infection in adults induces mild exacerbation of asthma associated with increased sputum concentrations of cysteinyl leukotrienes. Int Arch Allergy Immunol. 2005; 138:267–272. PMID: 16215328.
Article
15. Kloepfer KM, Olenec JP, Lee WM, Liu G, Vrtis RF, Roberg KA, et al. Increased H1N1 infection rate in children with asthma. Am J Respir Crit Care Med. 2012; 185:1275–1279. PMID: 22366048.
Article
16. Roh EJ, Jin YM, Chung EH, Rheem I, Kim JK. The prevalence of respiratory viral infection in exacerbation of asthma in hospitalized children. Korean J Asthma Allergy Clin Immunol. 2007; 27:241–247.
Article
17. Chung JY, Han TH, Kim BE, Kim CK, Kim SW, Hwang ES. Human metapneumovirus infection in hospitalized children with acute respiratory disease in Korea. J Korean Med Sci. 2006; 21:838–842. PMID: 17043416.
Article
18. Chung JY, Han TH, Kim SW, Kim CK, Hwang ES. Detection of viruses identified recently in children with acute wheezing. J Med Virol. 2007; 79:1238–1243. PMID: 17597481.
Article
19. Foster CB, Friedman N, Carl J, Piedimonte G. Enterovirus D68: a clinically important respiratory enterovirus. Cleve Clin J Med. 2015; 82:26–31. PMID: 25552624.
Article
20. Ralston SL, Lieberthal AS, Meissner HC, Alverson BK, Baley JE, Gadomski AM, et al. Clinical practice guideline: the diagnosis, management, and prevention of bronchiolitis. Pediatrics. 2014; 134:e1474–e1502. PMID: 25349312.
Article
21. Lin JA, Madikians A. From bronchiolitis guideline to practice: a critical care perspective. World J Crit Care Med. 2015; 4:152–158. PMID: 26261767.
Article
22. Henderson FW, Collier AM, Clyde WA Jr, Denny FW. Respiratorysyncytial-virus infections, reinfections and immunity. A prospective, longitudinal study in young children. N Engl J Med. 1979; 300:530–534. PMID: 763253.
23. Glezen WP, Taber LH, Frank AL, Kasel JA. Risk of primary infection and reinfection with respiratory syncytial virus. Am J Dis Child. 1986; 140:543–546. PMID: 3706232.
Article
24. Carroll KN, Wu P, Gebretsadik T, Griffin MR, Dupont WD, Mitchel EF, et al. The severity-dependent relationship of infant bronchiolitis on the risk and morbidity of early childhood asthma. J Allergy Clin Immunol. 2009; 123:1055–1061. 1061.e1PMID: 19361850.
Article
25. Jackson DJ, Gangnon RE, Evans MD, Roberg KA, Anderson EL, Pappas TE, et al. Wheezing rhinovirus illnesses in early life predict asthma development in high-risk children. Am J Respir Crit Care Med. 2008; 178:667–672. PMID: 18565953.
Article
26. Calşkan M, Bochkov YA, Kreiner-Møller E, Bønnelykke K, Stein MM, Du G, et al. Rhinovirus wheezing illness and genetic risk of childhood-onset asthma. N Engl J Med. 2013; 368:1398–1407. PMID: 23534543.
Article
27. Centers for Disease Control and Prevention (US). CDC develops a new, faster lab test for Enterovirus D68 [Internet]. Atlanta (GA): Centers for Disease Control and Prevention;2014. cited 2017 May 13. Available from: http://www.cdc.gov/media/releases/2014/p1014-test-enterovirus-d68.
28. McIntyre CL, Knowles NJ, Simmonds P. Proposals for the classification of human rhinovirus species A, B and C into genotypically assigned types. J Gen Virol. 2013; 94:1791–1806. PMID: 23677786.
Article
29. Bochkov YA, Palmenberg AC, Lee WM, Rathe JA, Amineva SP, Sun X, et al. Molecular modeling, organ culture and reverse genetics for a newly identified human rhinovirus C. Nat Med. 2011; 17:627–632. PMID: 21483405.
Article
30. Monto AS. The seasonality of rhinovirus infections and its implications for clinical recognition. Clin Ther. 2002; 24:1987–1997. PMID: 12581541.
Article
31. Johnston NW, Johnston SL, Duncan JM, Greene JM, Kebadze T, Keith PK, et al. The September epidemic of asthma exacerbations in children: a search for etiology. J Allergy Clin Immunol. 2005; 115:132–138. PMID: 15637559.
Article
32. Gern JE, Galagan DM, Jarjour NN, Dick EC, Busse WW. Detection of rhinovirus RNA in lower airway cells during experimentally induced infection. Am J Respir Crit Care Med. 1997; 155:1159–1161. PMID: 9117003.
Article
33. Kim JH, Kim YS, Cho GS, Kim NH, Gong CH, Lee BJ, et al. Human rhinovirus-induced proinflammatory cytokine and Interferon-β responses in nasal epithelial cells from chronic rhinosinusitis patients. Allergy Asthma Immunol Res. 2015; 7:489–496. PMID: 26122508.
Article
34. Handzel ZT, Busse WW, Sedgwick JB, Vrtis R, Lee WM, Kelly EA, et al. Eosinophils bind rhinovirus and activate virus-specific T cells. J Immunol. 1998; 160:1279–1284. PMID: 9570544.
35. Rosenberg HF, Domachowske JB. Eosinophils, eosinophil ribonucleases, and their role in host defense against respiratory virus pathogens. J Leukoc Biol. 2001; 70:691–698. PMID: 11698487.
36. Chihara J, Urayama O, Tsuda A, Kakazu T, Higashimoto I, Yamada H. Eosinophil cationic protein induces insulin-like growth factor I receptor expression on bronchial epithelial cells. Int Arch Allergy Immunol. 1996; 111(Suppl 1):43–45. PMID: 8906112.
Article
37. Papi A, Johnston SL. Rhinovirus infection induces expression of its own receptor intercellular adhesion molecule 1 (ICAM-1) via increased NF-kappaB-mediated transcription. J Biol Chem. 1999; 274:9707–9720. PMID: 10092659.
38. Bønnelykke K, Sleiman P, Nielsen K, Kreiner-Møller E, Mercader JM, Belgrave D, et al. A genome-wide association study identifies CDHR3 as a susceptibility locus for early childhood asthma with severe exacerbations. Nat Genet. 2014; 46:51–55. PMID: 24241537.
Article
39. Papadopoulos NG, Gourgiotis D, Javadyan A, Bossios A, Kallergi K, Psarras S, et al. Does respiratory syncytial virus subtype influences the severity of acute bronchiolitis in hospitalized infants? Respir Med. 2004; 98:879–882. PMID: 15338801.
Article
40. Oliveira TF, Freitas GR, Ribeiro LZ, Yokosawa J, Siqueira MM, Portes SA, et al. Prevalence and clinical aspects of respiratory syncytial virus A and B groups in children seen at Hospital de Clínicas of Uberlândia, MG, Brazil. Mem Inst Oswaldo Cruz. 2008; 103:417–422. PMID: 18797752.
Article
41. Liu AH, Covar RA, Spahn JD, Leung DY. Childhood asthma. In : Kliegman RM, Behrman RE, Jenson HB, Stanton BF, editors. Nelson textbook of pediatrics. 18th ed. Philadelphia (PA): Saunders Elsevier;2007. p. 953–970.
42. Peebles RS Jr, Graham BS. Pathogenesis of respiratory syncytial virus infection in the murine model. Proc Am Thorac Soc. 2005; 2:110–115. PMID: 16113477.
Article
43. Welliver RC, Garofalo RP, Ogra PL. Beta-chemokines, but neither T helper type 1 nor T helper type 2 cytokines, correlate with severity of illness during respiratory syncytial virus infection. Pediatr Infect Dis J. 2002; 21:457–461. PMID: 12150192.
Article
44. Openshaw PJ, Tregoning JS. Immune responses and disease enhancement during respiratory syncytial virus infection. Clin Microbiol Rev. 2005; 18:541–555. PMID: 16020689.
Article
45. Matsuse H, Tsuchida T, Fukahori S, Kawano T, Tomari S, Matsuo N, et al. Differential airway inflammatory responses in asthma exacerbations induced by respiratory syncytial virus and influenza virus a. Int Arch Allergy Immunol. 2013; 161:378–382. PMID: 23689185.
Article
46. Noah TL, Becker S. Chemokines in nasal secretions of normal adults experimentally infected with respiratory syncytial virus. Clin Immunol. 2000; 97:43–49. PMID: 10998316.
Article
47. Haeberle HA, Kuziel WA, Dieterich HJ, Casola A, Gatalica Z, Garofalo RP. Inducible expression of inflammatory chemokines in respiratory syncytial virus-infected mice: role of MIP-1α in lung pathology. J Virol. 2001; 75:878–890. PMID: 11134301.
Article
48. Borish L, Rosenwasser LJ. Cytokines in allergic inflammation. In : Adkinson NF, Yunginger JW, Busse WW, Bochner BS, Holgate ST, Simons FE, editors. Middleton's allergy principles & practice. 6th ed. St. Louis (MO): Mosby;2003. p. 135–157.
49. Kim CK, Kita H, Callaway Z, Kim HB, Choi J, Fujisawa T, et al. The roles of a Th2 cytokine and CC chemokine in children with stable asthma: potential implication in eosinophil degranulation. Pediatr Allergy Immunol. 2010; 21:e697–e704. PMID: 20444156.
Article
50. Hull J, Rowlands K, Lockhart E, Moore C, Sharland M, Kwiatkowski D. Variants of the chemokine receptor CCR5 are associated with severe bronchiolitis caused by respiratory syncytial virus. J Infect Dis. 2003; 188:904–907. PMID: 12964123.
Article
51. Hoebee B, Bont L, Rietveld E, van Oosten M, Hodemaekers HM, Nagelkerke NJ, et al. Influence of promoter variants of interleukin-10, interleukin-9, and tumor necrosis factor-alpha genes on respiratory syncytial virus bronchiolitis. J Infect Dis. 2004; 189:239–247. PMID: 14722888.
52. Meissner C, Storch GA. Picornaviruses: polio virus, other enteroviruses, and the rhinoviruses. In : Schaechter M, Engleberg NC, Eisenstein BI, Medoff G, editors. Mechanisms of microbial disease. 3rd ed. Philadelphia (PA): Lippincott Williams & Wilkins;1999. p. 305–314.
53. Smura T, Ylipaasto P, Klemola P, Kaijalainen S, Kyllönen L, Sordi V, et al. Cellular tropism of human enterovirus D species serotypes EV-94, EV-70, and EV-68 in vitro: implications for pathogenesis. J Med Virol. 2010; 82:1940–1949. PMID: 20872722.
54. Imamura T, Okamoto M, Nakakita S, Suzuki A, Saito M, Tamaki R, et al. Antigenic and receptor binding properties of enterovirus 68. J Virol. 2014; 88:2374–2384. PMID: 24371050.
Article
55. Karnauchow TM, Tolson DL, Harrison BA, Altman E, Lublin DM, Dimock K. The HeLa cell receptor for enterovirus 70 is decay-accelerating factor (CD55). J Virol. 1996; 70:5143–5152. PMID: 8764022.
Article
56. Soto-Quiros M, Avila L, Platts-Mills TA, Hunt JF, Erdman DD, Carper H, et al. High titers of IgE antibody to dust mite allergen and risk for wheezing among asthmatic children infected with rhinovirus. J Allergy Clin Immunol. 2012; 129:1499–1505.e5. PMID: 22560151.
Article
57. Gern JE, Vrtis R, Grindle KA, Swenson C, Busse WW. Relationship of upper and lower airway cytokines to outcome of experimental rhinovirus infection. Am J Respir Crit Care Med. 2000; 162:2226–2231. PMID: 11112143.
Article
58. Parry DE, Busse WW, Sukow KA, Dick CR, Swenson C, Gern JE. Rhinovirus-induced PBMC responses and outcome of experimental infection in allergic subjects. J Allergy Clin Immunol. 2000; 105:692–698. PMID: 10756217.
Article
59. Papadopoulos NG, Stanciu LA, Papi A, Holgate ST, Johnston SL. Rhinovirus-induced alterations on peripheral blood mononuclear cell phenotype and costimulatory molecule expression in normal and atopic asthmatic subjects. Clin Exp Allergy. 2002; 32:537–542. PMID: 11972599.
Article
60. Wark PA, Johnston SL, Bucchieri F, Powell R, Puddicombe S, Laza-Stanca V, et al. Asthmatic bronchial epithelial cells have a deficient innate immune response to infection with rhinovirus. J Exp Med. 2005; 201:937–947. PMID: 15781584.
Article
61. Busse WW, Morgan WJ, Gergen PJ, Mitchell HE, Gern JE, Liu AH, et al. Randomized trial of omalizumab (anti-IgE) for asthma in innercity children. N Engl J Med. 2011; 364:1005–1015. PMID: 21410369.
Article
62. Peltola V, Heikkinen T, Ruuskanen O, Jartti T, Hovi T, Kilpi T, et al. Temporal association between rhinovirus circulation in the community and invasive pneumococcal disease in children. Pediatr Infect Dis J. 2011; 30:456–461. PMID: 21200362.
Article
63. Harford CG, Leidler V, Hara M. Effect of the lesion due to influenza virus on the resistance of mice to inhaled pneumococci. J Exp Med. 1949; 89:53–68. PMID: 18099165.
Article
64. Cardenas PA, Cooper PJ, Cox MJ, Chico M, Arias C, Moffatt MF, et al. Upper airways microbiota in antibiotic-naïve wheezing and healthy infants from the tropics of rural Ecuador. PLoS One. 2012; 7:e46803. PMID: 23071640.
Article
65. Bisgaard H, Hermansen MN, Buchvald F, Loland L, Halkjaer LB, Bønnelykke K, et al. Childhood asthma after bacterial colonization of the airway in neonates. N Engl J Med. 2007; 357:1487–1495. PMID: 17928596.
Article
66. Gern JE. Viral respiratory infection and the link to asthma. Pediatr Infect Dis J. 2004; 23:S78–S86. PMID: 14730274.
Article
67. Kloepfer KM, Sarsani VK, Poroyko V, Lee WM, Pappas TE, Kang T, et al. Community-acquired rhinovirus infection is associated with changes in the airway microbiome. J Allergy Clin Immunol. 2017; 140:312–315.e8. PMID: 28327377.
Article
68. Stokholm J, Chawes BL, Vissing NH, Bjarnadóttir E, Pedersen TM, Vinding RK, et al. Azithromycin for episodes with asthma-like symptoms in young children aged 1–3 years: a randomised, double-blind, placebo-controlled trial. Lancet Respir Med. 2016; 4:19–26. PMID: 26704020.
Article
Full Text Links
  • AAIR
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr